JAK2^V617F to JAK2^WTpro-thrombotic cross talk. JAK2^V617F CHIP is associated with an increased arterial thrombosis risk, resulting from a thromboxane A2–mediated JAK2^V617F to JAK2^WT platelets activating cross talk.